-
1 Comment
Tibet Rhodiola Pharmaceutical Holding Co is currently in a long term downtrend where the price is trading 4.8% below its 200 day moving average.
From a valuation standpoint, the stock is 9.7% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 8.7.
Tibet Rhodiola Pharmaceutical Holding Co's total revenue rose by 18.1% to $384M since the same quarter in the previous year.
Its net income has increased by 27.8% to $94M since the same quarter in the previous year.
Finally, its free cash flow grew by 1.8% to $99M since the same quarter in the previous year.
Based on the above factors, Tibet Rhodiola Pharmaceutical Holding Co gets an overall score of 4/5.
| ISIN | CNE000000ZW7 |
|---|---|
| Sector | Healthcare |
| Exchange | SHG |
| CurrencyCode | CNY |
| Industry | Drug Manufacturers - Specialty & Generic |
| Market Cap | 14B |
|---|---|
| PE Ratio | 14.77 |
| Target Price | 59.2 |
| Dividend Yield | 4.1% |
| Beta | 0.38 |
Tibet Rhodiola Pharmaceutical Holding Co. produces and sells pharmaceutical products in China and internationally. The company offers modern Tibetan Medicines, including Nodikang capsules and granules, snow mountain golden arhat pain relief film, and ten-flavor Tida capsules; modern Chinese medicines, such as children Shuangqing granules, lipid clearing capsules, ginseng and zhi capsules, puyu capsules, and epilepsy flat film; and recombinant human brain natriuretic peptide for injection. It also provides isosorbide mononitrate sustained-release tablets; and oxygen rhodiola rosea moisturizing essence, secret recipe fragrance powder packet, rhodiola rosea, and Yuan Yang rhodiola rosea moisturizing essence products. In addition, the company offers biopharmaceuticals, traditional Chinese medicine, and chemical drugs for various fields, such as cardiovascular and cerebrovascular diseases, hepatobiliary diseases, orthopedic pain relief, rheumatism, and cold medicines. The company was founded in 1999 and is headquartered in Lhasa, China.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 600211.SHG using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2026
